At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Risperidone +1 moredrug
Likely dose
Risperidone 2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers
In Brief
A clinical study evaluating Risperidone and Placebo for Imaging of the Brain and Antipsychotics and Neuronal Network Changes. Completed, enrolled 11 participants across 1 site.
Detailed Summary
To detect the effect of second-generation antipsychotic drug on the neural activity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedAug 2013
Primary CompletionJul 2016
TodayJul 2026
First PostedAug 29, 2013
Enrollment StartJul 1, 2013
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 12.8 years ago
Interventions
Risperidonedrug
We gave oral liquid of risperidone one time 1-2 mg depending on subject's weight.
Placeboother
We gave oral liquid without active risperidone (pt and provider were both double blinded)